PHR (Phreesia) Beta: 2.2416 (As of Jun. 25, 2026)


PHR Phreesia Inc PHR
65 GF Score
Price $9.28
GF Value $26.97
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Phreesia Beta?

Phreesia PHR -3.23% 65 Beta is 2.2416 as of Jun. 25, 2026. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Phreesia's Beta is 2.2416.


Phreesia  (NYSE:PHR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Phreesia Beta Related Terms


Phreesia Beta Historical Data

* Premium members only.

The historical data trend for Phreesia's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia Beta Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.67 0.63 0.49 2.01

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 1.15 1.47 2.01 2.32

PHR vs HSTM, WEAV, EVH: Beta Comparison

For the Health Information Services subindustry, Phreesia's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phreesia Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Beta distribution charts can be found below:

* The bar in red indicates where Phreesia's Beta falls into.


PHR
65GF Score
Phreesia Inc PHR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phreesia Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.2416 mean?
Phreesia (PHR) has a Beta of 2.2416 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Phreesia and its competitors.
Is Phreesia's Beta too high?
Phreesia's current Beta is 2.2416. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Beta compare to HSTM and WEAV?
Phreesia's Beta of 2.2416 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Phreesia and its competitors. Phreesia's current Beta is 2.2416. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $9.28 — trading 65.6% below its estimated fair value. The current Beta is 2.2416. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Phreesia (PHR), the current Beta is 2.2416 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of $9.28 is trading 65.6% below its estimated GF Value™ of $26.97. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for PHR:

  • Beta: 2.2416
  • GF Value™: $26.97 vs. price of $9.28 (65.6% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phreesia Business Description

Other Exchanges 19P:Germany
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for PHR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.28
Price
$26.97
GF Value